AbCellera Biologics's chart data is dated 2026-10-08. There is no active technical signal. There are 16 published signal records.
AbCellera Biologics last closed at $12.02 (-6.31%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -22.3×. Its overall grade ranks 110 of 738 stocks in Healthcare.
About this company
AbCellera Biologics last closed at $12.02 (-6.31%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 110/738
Valuation grade A-
Related stocks
- Eli LillyCustomer
AbCellera의 대표적 초기 항체발굴 협력 고객
- NovartisCustomer
항체 발굴·신약개발 협력 이력의 주요 제약 고객
- Bristol Myers SquibbCustomer
AbCellera의 항체 플랫폼 활용 가능성이 큰 대형 제약 고객
ETFs holding this stock
Virtus LifeSci Biotech Clinical Trials ETF
Details →About AbCellera Biologics
- What technical signals does AbCellera Biologics (ABCL) have?
- AbCellera Biologics current technical signals: no active technical signal.
- Is AbCellera Biologics a cup-and-handle pattern?
- No. AbCellera Biologics has no valid Cup signal right now.
- What published figures are available for AbCellera Biologics?
- Market cap: $3.6B. Trailing 12 months PER: -22.3×. Latest quarter PBR: 4.10×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about AbCellera Biologics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.